These results suggest that the clinical efficacy of SDD as an adjunctive treatment for periodontal disease is partially mediated through its ability to inhibit pathogen-induced TREM-1 activation, thereby attenuating the inflammatory response associated with periodontitis [75,77,136]. The gene discussed is TREM1; the disease is periodontitis.